BITTNERI PALSAM suukaudne lahus Eesti - eesti - Ravimiamet

bittneri palsam suukaudne lahus

richard bittner ag - taimsed preparaadid - suukaudne lahus - 500ml 1tk; 100ml 1tk; 250ml 1tk; 50ml 1tk

STREPSILS INTENSIVE ORANGE (SUHKRUVABA) loseng Eesti - eesti - Ravimiamet

strepsils intensive orange (suhkruvaba) loseng

reckitt benckiser (poland) s.a. - flurbiprofeen - loseng - 8,75mg 12tk; 8,75mg 36tk; 8,75mg 8tk; 8,75mg 24tk; 8,75mg 16tk

Sugammadex Mylan Euroopa Liit - eesti - EMA (European Medicines Agency)

sugammadex mylan

mylan ireland limited - sugammadex sodium - neuromuskulaarne blokaad - kõik muud ravitoimingud - reversal of neuromuscular blockade induced by   rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

Sugammadex Fresenius Kabi Euroopa Liit - eesti - EMA (European Medicines Agency)

sugammadex fresenius kabi

fresenius kabi deutschland gmbh - sugammadex sodium - neuromuskulaarne blokaad - kõik muud ravitoimingud - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

Sugammadex Amomed Euroopa Liit - eesti - EMA (European Medicines Agency)

sugammadex amomed

aop orphan pharmaceuticals gmbh - sugammadex sodium - neuromuskulaarne blokaad - kõik muud ravitoimingud - rookurooniumi või vekurooniumi poolt indutseeritud neuromuskulaarse blokaadi pöördumine. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

Sugammadex Adroiq Euroopa Liit - eesti - EMA (European Medicines Agency)

sugammadex adroiq

extrovis eu ltd. - sugammadex sodium - neuromuskulaarne blokaad - kõik muud ravitoimingud - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.